Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy

Conditions:   HRAS Gene Mutation;   HNSCC
Interventions:   Drug: Tipifarnib;   Device: HRAS Detection Assay
Sponsor:   Kura Oncology, Inc.
Not yet recruiting

https://ift.tt/2OONIgl